Press Releases
Acting FDA Commissioner Announced: HHS Secretary Appoints Dr. Norman E. Sharpless
Friends of Cancer Research Applauds This Appointment The Secretary of Health and Human Services (HHS) Alex M. Azar III has appointed Dr. Norman E. Sharpless
Friends of Cancer Research Celebrates the Life of Congressman John Dingell
Washington DC – Friends of Cancer Research (Friends) joins the nation in mourning the loss of former Democratic Representative John Dingell of Michigan. “For decades,
Lung-MAP Precision Medicine Trial Expands To Include More Patients
Washington, DC – The Lung Cancer Master Protocol (Lung-MAP), the first precision medicine trial in lung cancer supported by the National Cancer Institute (NCI), part
Friends of Cancer Research Announces New Members to Board of Directors
Friends Welcomes Margaret Anderson, Edward J. Benz Jr, and Elizabeth Thompson January 17, 2019 – Washington, DC – Friends of Cancer Research (Friends) is pleased
FDA Announces Dr. Amy Abernethy as Principal Deputy Commissioner of Food and Drugs
Friends of Cancer Research Applauds this Appointment and Thanks Dr. Rachel Sherman for Her Incredible Service December 17, 2018 – Washington, DC – Today, the
Friends of Cancer Research and ASCO Applaud NCI's Expansion of Clinical Trial Eligibility Criteria
WASHINGTON, DC – The American Society of Clinical Oncology, Inc. (ASCO) and Friends of Cancer Research (Friends) applaud the National Cancer Institute’s (NCI) recent revision
Friends of Cancer Research Releases Results of TMB Harmonization Project – Phase I
Results to be Presented at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting November 6, 2018 – Washington, DC – Friends of Cancer
Making Objective Drug Evidence Revisions for New Labeling Act Introduced to Senate
Senators Hatch and Bennet Introduce Bipartisan Solution to Important Public Health Issue September 28, 2018 – Washington, DC – Friends of Cancer Research (Friends) applauds
Friends of Cancer Research Announces Launch of Phase II TMB Harmonization Project
September 18, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) announced the launch of Phase II of its tumor mutational burden or
Two Cancer Research Organizations Submit Recommendations to FDA Aimed at Reducing Barriers to Clinical Trial Participation
August 9, 2018 – WASHINGTON, D.C. – The American Society of Clinical Oncology, Inc. (ASCO®) and Friends of Cancer Research (Friends) have submitted to the
